Summit Global Investments Eli Lilly & CO Transaction History

Summit Global Investments

$1.34 Billion
Q1 2024

A detailed history of Summit Global Investments transactions in Eli Lilly & CO stock. As of the latest transaction made, Summit Global Investments holds 2,991 shares of LLY stock, worth $2.71 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,991

Previous 2,386 25.36%

Holding current value

$2.71 Million

Previous $1.39 Million 67.29%

% of portfolio

0.17%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $358,281 - $479,329	605 Added 25.36%	2,991 $2.33 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $3.86 Million - $4.55 Million	-7,344 Reduced 75.48%	2,386 $1.39 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $143,016 - $197,169	-329 Reduced 3.27%	9,730 $5.23 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $3.53 Million - $4.72 Million	10,059 New	10,059 $4.72 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $1.87 Million - $2.3 Million	-8,431 Closed	0 $0

Q2 2021 Jan 28, 2022	SELL	$180.55 - $233.54 $964,137 - $1.25 Million	-5,340 Reduced 38.78%	8,431 $1.93 Million
Q1 2021 Jan 27, 2022	SELL	$164.32 - $212.72 $1.32 Million - $1.71 Million	-8,036 Reduced 36.85%	13,771 $2.57 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $5.28 Million - $6.98 Million	-40,439 Reduced 64.97%	21,807 $3.68 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $10.1 Million - $11.7 Million	-69,064 Reduced 52.6%	62,246 $9.21 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $456,324 - $549,182	3,345 Added 2.61%	131,310 $21.6 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $8.23 Million - $10.2 Million	69,119 Added 117.46%	127,965 $17.8 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $121,888 - $150,970	1,140 Added 1.98%	58,846 $7.73 Million
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $4.89 Million - $5.32 Million	45,772 Added 383.54%	57,706 $6.45 Million
Q2 2019 Aug 16, 2019	SELL	$110.79 - $129.32 $10.4 Million - $12.1 Million	-93,737 Reduced 88.71%	11,934 $1.32 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $3.59 Million - $4.23 Million	-32,287 Reduced 23.4%	105,671 $13.7 Million
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $790,331 - $885,410	7,463 Added 5.72%	137,958 $16 Million
Q3 2018 Nov 15, 2018	BUY	$85.86 - $107.31 $17,773 - $22,213	207 Added 0.16%	130,495 $14 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $7.95 Million - $9.12 Million	104,963 Added 414.46%	130,288 $11.1 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $1.2 Million - $1.41 Million	16,145 Added 175.87%	25,325 $1.96 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $752,209 - $806,830	9,180	9,180 $775,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account

Summit Global Investments Eli Lilly & CO Transaction History